Concepedia

Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized Trial

Laura E. Dichtel, Kathleen E. Corey, Melanie S. Haines, Mark L Chicote, Hang Lee, Allison Kimball, Caitlin Colling, Tracey G. Simon, Michelle T. Long, Jad S. Husseini,

The Journal of Clinical Endocrinology & Metabolism · 2023 · 27 citations · 27 references

DOIFull text

Open access

Abstract

GH administration reduces hepatic steatosis in adults with overweight/obesity and NAFLD without worsening glycemic measures. The GH/IGF-1 axis may lead to future therapeutic targets for NAFLD.

References

27

Estimation of metabolite concentrations from localized <i>in vivo</i> proton NMR spectra

Stephen W. Provencher · Magnetic Resonance in Medicine · 1993 · 3.7K citations

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

Eduardo Vilar‐Gómez, Yadina Martínez-Pérez, Luis Calzadilla Bertot et al. · Gastroenterology · 2015 · 2.3K citations · Full text

, , +14

Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition

RB Mazess, HS Barden, JP Bisek et al. · American Journal of Clinical Nutrition · 1990 · 1.5K citations

, , +11

Endpoints and clinical trial design for nonalcoholic steatohepatitis

Arun J. Sanyal, Elizabeth M. Brunt, David E. Kleiner et al. · Hepatology · 2011 · 749 citations · Full text

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

Naga Chalasani, Zobair M. Younossi, Joel E. Lavine et al. · The American Journal of Gastroenterology · 2012 · 589 citations